Skip to main content
. 2017 Aug 7;7:7386. doi: 10.1038/s41598-017-07782-9

Table 1.

Number of years of alternative interventions required to reach the site-specific 95% EP threshold after crossing the WHO 1% mf threshold.

VC Coverage Drug Regimen (Coverage) Yangwen 1st Yangwen 2nd Yangwen 3rd Yangwen 4th Sungisun Hseihchuang Lakshadweep Karaikal Little Kinmen Kwemwale/Nkumba Miton
VC 0% DEC Salt (60%) 0.5 0.7 0.7 0.7 0.6 0.7 1.1 0.7 0.7 2.4 2.0
DEC Salt (80%) 0.4 0.6 0.5 0.6 0.5 0.6 0.9 0.5 0.6 1.9 1.6
DEC Salt (100%) 0.3 0.4 0.4 0.5 0.4 0.5 0.8 0.4 0.5 1.6 1.4
Annual IDA (80%) 4.1 4.3 4.2 4.3 4.2 4.3 4.2 3.5 4.2 3.9 4.0
Annual MDA (80%) 6.5 6.7 6.6 6.5 6.3 6.7 6.5 5.6 6.3 5.7 5.9
Biannual MDA (80%) 2.8 3.0 2.8 2.9 2.8 2.9 2.9 2.3 2.9 2.7 2.8
VC 50% DEC Salt (60%) 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.5 0.2 0.1 0.4
DEC Salt (80%) 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.2 0.1 0.3
DEC Salt (100%) 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.3
Annual IDA (80%) 1.2 1.2 1.3 1.2 1.1 1.4 1.3 3.0 1.4 1.0 1.9
Annual MDA (80%) 2.5 2.4 2.5 2.4 2.2 2.7 2.6 5.0 2.6 1.7 3.0
Biannual MDA (80%) 0.8 0.8 0.8 0.7 0.6 0.9 0.8 1.9 0.9 0.5 1.0
VC 80% DEC Salt (60%) 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.5 0.2 0.1 0.4
DEC Salt (80%) 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.3
DEC Salt (100%) 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.3
Annual IDA (80%) 1.2 1.2 1.2 1.2 1.1 1.3 1.3 2.9 1.3 1.0 1.7
Annual MDA (80%) 2.4 2.4 2.5 2.4 2.2 2.6 2.5 4.9 2.5 1.6 2.9
Biannual MDA (80%) 0.8 0.7 0.8 0.7 0.6 0.9 0.8 1.9 0.8 0.5 1.0

The estimated mean number of years required to reduce mf prevalence to the 95% probability mf breakpoint threshold under each intervention in a particular site are reported.